טוען...
Antiangiogenic Tetrathiomolybdate Protects Against Her2/neu-induced Breast Carcinoma by Hypoplastic Remodeling of the Mammary Gland
PURPOSE: The development of cancer chemopreventative agents with increased safety profile is a major priority of cancer research. The objective of the present study was to delineate the efficacy of tetrathiomolybdate (TM), a novel antiangiogenic anticancer agent, as a chemopreventative agent. EXPERI...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3471244/ https://ncbi.nlm.nih.gov/pubmed/19934283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1361 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|